MCAM and obesity disorder: To determine whether AA98 anti‐CD146 antibodies were able to suppress obesity and related chronic inflammation in vivo, we treated 6 week old male db/db mice with either AA1 or AA98 anti‐CD146 antibodies or control mIgG via intraperitoneal injection twice a week.